| |
| |
|
| Insider
Information: |
Leung Sandra |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
348,885 |
|
|
Indirect Shares
|
100,721 |
|
|
| Direct
Value |
$14,409,530 |
|
|
|
Indirect Value
|
$4,177,907 |
|
|
| Total
Shares |
449,606 |
|
|
| Total
Value |
$18,587,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 7.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, General Counsel |
2024-03-10 |
347,385 |
2024-03-10 |
100,721 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,500 |
2009-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2019-02-28 |
4 |
OE |
$17.51 |
$2,974,826 |
D/D |
169,893 |
634,478 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2017-12-04 |
4 |
S |
$63.37 |
$9,922,601 |
D/D |
(156,582) |
427,791 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2017-12-04 |
4 |
OE |
$22.14 |
$3,466,725 |
D/D |
156,582 |
584,373 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2020-08-13 |
4 |
S |
$63.24 |
$8,943,401 |
D/D |
(141,420) |
432,744 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2019-02-28 |
4 |
D |
$51.86 |
$5,697,028 |
D/D |
(109,854) |
524,624 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2016-05-06 |
4 |
OE |
$24.74 |
$2,474,000 |
D/D |
100,000 |
444,507 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
99,937 |
292,758 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
81,203 |
228,185 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
76,455 |
115,595 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2016-05-06 |
4 |
S |
$70.39 |
$5,106,372 |
D/D |
(72,544) |
371,963 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,896 |
488,677 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,424 |
451,862 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2022-06-06 |
4 |
S |
$74.89 |
$4,867,850 |
D/D |
(65,000) |
308,627 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,273 |
388,747 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,990 |
356,920 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2014-03-03 |
4 |
D |
$53.49 |
$3,093,220 |
D/D |
(57,828) |
252,737 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2016-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,484 |
366,730 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• – – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
53,389 |
163,376 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,598 |
588,175 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,373 |
383,564 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
• – – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,483 |
61,268 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,784 |
371,312 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,170 |
558,854 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
• – – |
2022-03-10 |
4 |
D |
$68.42 |
$3,072,126 |
D/D |
(44,901) |
373,627 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
• • – |
2013-03-07 |
4 |
D |
$37.53 |
$1,670,385 |
D/D |
(44,508) |
191,345 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
